Fernandez-Pacheco M, Ortmann O, Ignatov A, Inwald E C
Department of Gynaecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053, Regensburg, Germany.
Arch Gynecol Obstet. 2023 Apr;307(4):1295-1309. doi: 10.1007/s00404-022-06512-5. Epub 2022 May 20.
Cavity shaving (CS) is a surgical technique used in the treatment of breast cancer (BC). It may reduce margin positivity in histologic assessment and consequently reduces re- excision rates in breast conserving surgery (BCS). The evidence for this assumption is described in the present review.
A systematic review of relevant literature in English from January 1999 to April 2019 was conducted. The analysis included studies on CS and its effects on re-excision rates and margin positivity. We searched PubMed databases for relevant publications. In total, 22 studies were included in the present review.
The benefit from CS on re-excision rates and histologic margin positivity was variable. Out of 22 studies, 17 reported a reduction in both re-excision rates and histologic margin positivity in margin shaved patients. Four studies could not find a significant reduction of second surgeries and residual tumor rates. One study suggested that CS after BCS was superior to single BCS only in subgroup analysis in IDC tumors.
CS is a surgical technique that was shown to reduce re-excision and margin positivity rates in most of the studies. Furthermore, it can be a useful tool to assess specimen margins and detect multifocality.
腔隙切除(CS)是一种用于治疗乳腺癌(BC)的手术技术。它可能会降低组织学评估中的切缘阳性率,从而降低保乳手术(BCS)中的再次切除率。本综述阐述了这一假设的证据。
对1999年1月至2019年4月期间的英文相关文献进行系统综述。分析包括关于CS及其对再次切除率和切缘阳性率影响的研究。我们在PubMed数据库中搜索相关出版物。本综述共纳入22项研究。
CS对再次切除率和组织学切缘阳性率的益处存在差异。在22项研究中,17项报告称切缘切除患者的再次切除率和组织学切缘阳性率均有所降低。4项研究未发现二次手术和残留肿瘤率有显著降低。一项研究表明,在浸润性导管癌(IDC)肿瘤的亚组分析中,BCS后的CS仅优于单纯BCS。
在大多数研究中,CS是一种能降低再次切除率和切缘阳性率的手术技术。此外,它可以作为评估标本切缘和检测多灶性的有用工具。